A Prospective Study of Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy for Siewert II ，III of Locally Advanced HER-2 Negative Adenocarcinoma at Gastroesophageal Junction
Clinical trial NCT03349866 · UNKNOWN
Trial details
- NCT number
- NCT03349866
- Sponsor
- Hebei Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-30
- Primary completion
- 2019-11-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.